Immediate reaction to ibrutinib amenable to oral desensitization.
Neelam A PhadkeSamantha O LukEphraim P HochbergAleena BanerjiPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
As indications for ibrutinib use expand and more patients present with IgE-mediated symptoms, we expect that this protocol will provide benefit for many such patients.